Cargando…
Structure Based docking studies towards exploring potential anti-androgen activity of selected phytochemicals against Prostate Cancer
Prostate cancer (PCa) is the second most common malignancy amongst men worldwide. Under PCa maintenance therapy drugs acting as antagonists/partial agonists of hormone receptors against the prostate tissue are used in clinical practices. Prominent drugs being Cyproterone acetate, Flutamide, Bicaluta...
Autores principales: | Singh, Anshika N., Baruah, Meghna M., Sharma, Neeti |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5434041/ https://www.ncbi.nlm.nih.gov/pubmed/28512306 http://dx.doi.org/10.1038/s41598-017-02023-5 |
Ejemplares similares
-
Identification of key pathways and genes with aberrant methylation in prostate cancer using bioinformatics analysis
por: Singh, Anshika N, et al.
Publicado: (2017) -
Quantitative SWATH-Based Proteomic Profiling for Identification of Mechanism-Driven Diagnostic Biomarkers Conferring in the Progression of Metastatic Prostate Cancer
por: Singh, Anshika N., et al.
Publicado: (2020) -
Evaluation of Hymenodictyon excelsum Phytochemical’s Therapeutic Value Against Prostate Cancer by Molecular Docking Study
por: Rahman, Mohammad Mijanur
Publicado: (2015) -
In-silico docking studies of selected phytochemicals against papain like protease of SARS-Cov-2
por: Saranya, Palanisamy, et al.
Publicado: (2022) -
Combination of quercetin and 2-methoxyestradiol inhibits epithelial–mesenchymal transition in PC-3 cell line via Wnt signaling pathway
por: Sharma, Neeti, et al.
Publicado: (2021)